期刊文献+

葛根异黄酮类化合物抗动脉粥样硬化药理研究进展 被引量:18

Progress in the pharmaceutical study of Radix puerariae
原文传递
导出
摘要 动脉粥样硬化(Atherosclerosis,AS)是当今导致心脑血管疾病高发的主要因素,越来越多的报道说明中药葛根具有抗动脉粥样硬化的药理作用,其主要有效成分为异黄酮类化合物,以葛根素(puerarin)、大豆苷元(daidzein)和大豆苷(daidzin)研究最多,药理作用也最明显。文中对近年来葛根及其有效成分在动脉粥样硬化方面的研究进行综述。 Atherosclerosis,a progressive disease characterized by the accumulation of lipids and fibrous elements in the large arteries,underlies the vast majority of cardiovascular disease and causes more death and disability worldwide than any other disease.The growing reports show that Radix puerariae(Gegeng),one of the most famous Chinese medicines,can inhibit the progression of atherosclerotic lesions.Isoflavonoids,such as puerarin,daidzein and daidzin,were considered as the main active components in Radix puerariae.In the present paper,the atheroprotective effects of Radix puerariae and its components have been reviewed and discussed.
出处 《中国新药杂志》 CAS CSCD 北大核心 2010年第8期662-665,共4页 Chinese Journal of New Drugs
基金 澳门科技发展基金(078/2005/A2 049/2005/A-R1)
关键词 动脉粥样硬化 葛根 葛根素 大豆苷 大豆苷元 atherosclerosis Radix puerariae puerarin daidzin daidzein
  • 相关文献

参考文献31

  • 1MENSAH GA, BROWN DW. An overview of cardiovascular disease burden in the United States [ J ]. Health Affairs, 2007,26 (1) :38 -48.
  • 2郭长彬,李松.抗动脉粥样硬化药物研究进展[J].药学学报,2007,42(3):231-235. 被引量:4
  • 3FOX KM, GANDHI SK, BLASETTO JW, et al. Dyslipidemia treatment patterns and low-density lipaprotein cholesterol monitoring and management of patients with atheroselerosis in realworld clinical practice. Presented at: the American Heart Association Quality of Care and Outcomes Research in Cardiovascular disease and Stroke meeting[J]. Circulation,2007,29:572.
  • 4CANNON CP, BRAUNWALD E, MCCABE CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes [ J ]. N Engl J Med,2004,350 ( 15 ) : 1495 - 1504.
  • 5马杰,陈剑秋.中医药防治动脉粥样硬化的研究概况[J].江苏中医药,2007,39(12):80-82. 被引量:16
  • 6Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel Ⅲ ) [ J ]. JAMA, 2001,285 ( 19 ) : 2486 - 2497.
  • 7SMITH SC, ALLEN J, BLAIR SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update[ J ]. J Am Coll Cardiol, 2006,47(10) :2130 -2139.
  • 8李强翔,钟惠菊,周敏,贺金莲,李玮,吴群,李果,张颖.葛根素对糖尿病大鼠血脂和主动脉细胞间粘附分子-1表达的调控[J].中国行为医学科学,2006,15(11):981-983. 被引量:15
  • 9赵瑛,李蔚,祖莹,王巍.葛根素对实验性代谢综合征大鼠血脂影响的研究[J].中国中医药科技,2007,14(1):29-30. 被引量:14
  • 10RAHMAN MM, VARGHESE Z, FULLER BJ, et al. Renal vasoconstriction induced by oxidized LDL inhibited by scavengers of reactive oxygen species and L2 arginice[ J]. Clin Nephrol, 1999, 51(2) :98 -107.

二级参考文献169

共引文献2341

同被引文献309

引证文献18

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部